Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.
- Conditions
- Colic, InfantileVomiting; CyclicalGastroesophageal RefluxConstipation - FunctionalDiarrheaDyscheziaFunctional Gastrointestinal Disorders
- Registration Number
- NCT06031025
- Brief Summary
The goal of this observational study is to learn about the prevalence and characteristics of functional gastrointestinal disorders (FGID) in at risk infants (former preterm infants and those with birth asphyxia) during the first 2 years of life. The main questions it aims to answer are:
* evaluate the prevalence of symptoms related to gastro-esophageal reflux (GER), of functional gastrointestinal disorders during the first 2 years of life
* describe growth parameters during follow-up up to the corrected age of 2 years Participants will be assessed clinically and with a structured questionnaire based on the Rome IV criteria to describe FGID.
- Detailed Description
Infants will undergo clinical assessment at 3, 6, 12, 24 months' corrected age at the local Follow-up clinic.
Clinical examination, anthropometric measurement and data from a structured questionnaire to detect FGID will be performed.
Z-scores for weight, length and head circumference will be calculated according to the World Health Organization (WHO) standards.
Data from the questionnaires will be collected. Clinical characteristics of patients and perinatal data will be collected and analyzed by appropriate statistical methods.
The prevalence and characteristics of FGID in the study population will be compared to published data (mostly from term infants).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 71
- infants with gestational age at birth < 31 weeks
- infants with gestational age at birth < 37 weeks and major respiratory or neurologic morbidity
- infants with history of perinatal asphyxia
- lack of informed consent
- diagnosis of congenital or other major gastrointestinal disease (i.e. inflammatory bowel disease, cancer)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of FGID 3, 6, 12, 24 months of corrected age Occurrence of FGID (percentage of patients)
Frequency of FGID 3, 6, 12, 24 months of corrected age Frequency of FGID (i.e. number of symptoms per day)
Severity of FGID 3, 6, 12, 24 months of corrected age Severity (scales from 0 to 10 for increasing values) of FGID
- Secondary Outcome Measures
Name Time Method Somatic growth: weight 3, 6, 12, 24 months of corrected age Measurement of weight and calculation of z-scores based on reference standards by the World Health Organization
Somatic growth: head circumference 3, 6, 12, 24 months of corrected age Measurement of head circumference and calculation of z-scores based on reference standards by the World Health Organization
Somatic growth: length 3, 6, 12, 24 months of corrected age Measurement of length and calculation of z-scores based on reference standards by the World Health Organization
Trial Locations
- Locations (1)
Fondazione Policlinico Gemelli IRCCS
🇮🇹Roma, Italy